Loading page content...
Back to All Products
Gastroenterology View All Products
DEXLEAD-DSR
A Leadwell Pharmaceuticals Brand
Dual-action therapy for acid-related gastrointestinal disorders with sustained symptom control.
Marketed by Leadwell Pharmaceuticals
DEXLEAD-DSR is a prescription gastrointestinal formulation combining Dexrabeprazole Modified Release with Domperidone Sustained Release to support acid suppression and gastric motility in patients with acid-related disorders.
Dosage Form
Modified Release Capsules
Category
Gastroenterology
Product Overview
About DEXLEAD-DSR
DEXLEAD-DSR combines a proton pump inhibitor with a prokinetic agent to provide comprehensive management of acid-related gastrointestinal conditions. Dexrabeprazole helps reduce gastric acid secretion, while Domperidone supports normal gastric emptying and gastrointestinal motility.
Formula
Composition
IngredientQuantity
Dexrabeprazole Modified Release60 mg
Domperidone Sustained Release30 mg
Ingredient Profile
Key Ingredients
Dexrabeprazole Modified Release
A proton pump inhibitor that suppresses gastric acid secretion and supports healing of acid-related gastrointestinal conditions.
Domperidone Sustained Release
A prokinetic agent that supports gastric motility and helps relieve symptoms associated with delayed gastric emptying.
Product Highlights
Why This Formulation
Dual-action acid suppression and prokinetic therapy
Supports relief from acid reflux symptoms
Helps maintain normal gastric motility
Suitable for acid-related gastrointestinal disorders
Modified and sustained release formulation
Prescription gastrointestinal medicine
Product Information
Used in the management of gastroesophageal reflux disease (GERD), acid reflux, erosive esophagitis, gastritis, dyspepsia and associated nausea or vomiting, as directed by a registered medical practitioner.
Directions for Use
Use only in the dose and duration prescribed by a registered medical practitioner. Capsules should be taken as advised by the physician.
Storage
Store in a cool and dry place below 25°C, protected from moisture and direct sunlight. Keep out of reach of children.
For the use of a registered medical practitioner, hospital or laboratory only. This information is intended for healthcare professionals and educational purposes. It is not a substitute for medical advice, diagnosis or treatment.
Explore More
Related Products
Gastroenterology
ESOSTART-40
ESOSTART-40 contains Esomeprazole 40 mg, a proton pump inhibitor formulated to provide effective gastric acid suppression for the management of acid-related disorders.
View ProductGastroenterology
ESOSTART-DSR
ESOSTART-DSR is a combination of Esomeprazole Enteric Coated 40 mg and Domperidone Sustained Release 30 mg formulated for the management of acid-related gastrointestinal disorders.
View Product